Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
United Kingdom
Biotech
Syncona cites 'challenging' market for switching investment plan
Life sciences firm Syncona has blamed “particularly challenging” market conditions for shifting its strategy away from early-stage biotechs.
James Waldron
Jun 20, 2025 6:00am
UK professional orgs call for actions to improve trial diversity
Jun 17, 2025 3:30pm
BioNTech makes £1B commitment to expand UK research, build HQ
May 20, 2025 11:15am
Brexit-linked costs threaten UK cancer care, research: report
Apr 21, 2025 10:35am
UK rolls out new clinical trial reforms
Apr 14, 2025 1:55pm
Sofinnova closes €165M European biotech acceleration fund
Mar 18, 2025 4:01am
